Cite
HARVARD Citation
Armuzzi, A. et al. (2019). The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy. Inflammatory bowel diseases. 25 (3), pp. 568-579. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Armuzzi, A. et al. (2019). The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy. Inflammatory bowel diseases. 25 (3), pp. 568-579. [Online].